Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion type Assertion NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_head.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion description "[These tumors account for 12-17 % of all breast cancers, preferentially affect young women, are more frequent in women of African and Hispanic descent, and are enriched in the population of patients diagnosed with interval cancers. TNBCs account for the majority of breast cancers arising in BRCA1 germline mutation carriers (approximately 80%), and approximately 11-16% of all TNBCs harbor BRCA1 or BRCA2 germline mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion evidence source_evidence_literature NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion SIO_000772 25527230 NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion wasDerivedFrom befree-2016 NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.
- NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_assertion wasGeneratedBy ECO_0000203 NP1249861.RA-6i87HrjgL8jIEa2bEbWeJznLyjYmSi73tO3l0qB8IE130_provenance.